YANGZHOU, China, Aug. 26,
2024 /PRNewswire/ -- Meihua International
Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq:
MHUA), a reputable manufacturer and provider of Class I, II, and
III disposable medical devices with operating subsidiaries in
China, today announced that Xin
"Steven" Wang, Chief Executive Officer of Meihua, will present and
discuss recent corporate events at LIVE! with Webull Corporate
Connect: Virtual Healthcare Investment Webinar on Wednesday, August 28, 2024, at 3:00 PM ET.
Conference Details:
Conference: LIVE! with Webull Corporate Connect: Virtual
Healthcare Investment Webinar
Date/Time: Wednesday, August 28,
2024, at 3:00 PM ET
Presenter: Xin "Steven" Wang, Chief Executive Officer of
Meihua
Registration Link:
https://us02web.zoom.us/webinar/register/WN_E-VdYojiQ9eGpDCKB3lz2g
About Meihua International Medical Technologies Co.,
Ltd.
Meihua International Medical Technologies is a reputable
manufacturer and provider of Class I, II and III disposable medical
devices with operating subsidiaries in China. The Company manufactures and sells
Class I disposable medical devices, such as HDPE bottles for
tablets and LDPE bottles for eye drops, throat strips and anal
bags, as well as Class II and III disposable medical devices, such
as disposable identification bracelets, gynecological examination
kits, inspection kits, surgical kits, medical brushes, medical
dressing, medical catheters, uterine tissue suction tables, virus
sampling tubes, disposable infusion pumps, electronic pumps and
anesthesia puncture kits, among other products which are sold under
Meihua's own brands and are also sourced and distributed from other
manufacturers. The Company has received an international "CE"
certification and ISO 13485 system certification and has also
registered with the FDA (registration number: 3006554788) for more
than 20 Class I products. The Company has served hospitals,
pharmacies, medical institutions and medical equipment companies
for more than 30 years, providing over 1,000 types of products for
domestic sales, as well as more than120 products which are exported
to more than 30 countries internationally across Europe, North
America, South America,
Asia, Africa and Oceania.
For more information, please visit www.meihuamed.com.
Follow us on Webull:
https://www.webull.com/quote/nasdaq-mhua.
About Webull
Webull Financial LLC ("Webull Financial") is a leading online
brokerage platform committed to empowering self-directed investors
with innovative tools and cutting-edge technology. With low-cost
trading on a wide range of assets, advanced charting tools, and
real-time market data, Webull Financial is revolutionizing the way
individuals approach investing. The user-centric approach and
commitment to staying at the forefront of industry trends
underscore the mission to provide a seamless and rewarding
experience for traders of all levels. Through the Webull Group,
Webull Financial and its affiliates combine to serve tens of
millions of users from over 180 countries worldwide. Securities and
futures trading is offered to customers by Webull Financial, a
broker-dealer registered with the Securities and Exchange
Commission (SEC) and a futures commission merchant registered with
the Commodity Futures Trading Commission (CFTC). Webull Financial
is also a member of the Financial Industry Authority (FINRA), the
National Futures Association (NFA), and the Securities Investor
Protection Corporation (SIPC). Webull Financial's holding company,
Webull Corporation, is a Cayman
Islands corporation headquartered in St. Petersburg, FL, and owned by a diverse
group of investors from the United
States, Europe, and
Asia. All investing is subject to
risk, including the possible loss of principal. For more
information about Webull, visit www.webull.com.
Forward-Looking Statements
This press release contains forward-looking statements as
defined by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events or performance, and
underlying assumptions and other statements that are other than
statements of historical facts. When the Company uses words such as
"may," "will," "intend," "should," "believe," "expect,"
"anticipate," "project," "estimate" or similar expressions that do
not relate solely to historical matters, it is making
forward-looking statements. Forward-looking statements are not
guarantees of future performance and involve risks and
uncertainties that may cause the actual results to differ
materially from the Company's expectations discussed in the
forward-looking statements. These statements are subject to
uncertainties and risks including, but not limited to, the
following: the Company's ability to achieve its goals and
strategies, the Company's future business development and plans of
future business development, including its ability to successfully
develop robotic assisted surgery systems and obtain licensure and
certification for such systems, financial conditions and results of
operations, product and service demand and acceptance, reputation
and brand, the impact of competition and pricing, changes in
technology, government regulations, fluctuations in general
economic and business conditions in China, and assumptions underlying or related
to any of the foregoing and other risks contained in reports filed
by the Company with the SEC. For these reasons, among others,
investors are cautioned not to place undue reliance upon any
forward-looking statements in this press release. Additional
factors are discussed in the Company's filings with the SEC,
including under the section entitled "Risk Factors" in its annual
report on Form 20-F, as well as on Form 6-K and other filings, all
of which are available for review at www.sec.gov. The Company
undertakes no obligation to publicly revise these forward-looking
statements to reflect events or circumstances that arise after the
date hereof.
For investor and media inquiries, please
contact:
IR Department
Email:
secretary@meihuamed.com
Tel: +86-0514-89800199
Christensen
Dee Wang
Email: dee.wang@christensencomms.com
Tel: +86-010-59001548
View original
content:https://www.prnewswire.com/news-releases/meihua-international-medical-technologies-co-ltd-to-present-at-live-with-webull-corporate-connect-virtual-healthcare-investment-webinar-on-august-28-2024-302230308.html
SOURCE Meihua International Medical Technologies Co., Ltd.